Attenuation of arthritis in rodents by a novel orally-available inhibitor of sphingosine kinase. (Q50539105)

15 March 2018

title

Attenuation of arthritis in rodents by a novel orally-available inhibitor of sphingosine kinase. (English)

1 reference

15 March 2018

author

Timothy J. Mosher

10

1 reference

15 March 2018

author name string

Leo R Fitzpatrick

1

1 reference

15 March 2018

Cecelia Green

2

1 reference

15 March 2018

Elizabeth E Frauenhoffer

3

1 reference

15 March 2018

Kevin J French

4

1 reference

15 March 2018

Yan Zhuang

5

1 reference

15 March 2018

Lynn W Maines

6

1 reference

15 March 2018

John J Upson

7

1 reference

15 March 2018

Emmanuel Paul

8

1 reference

15 March 2018

Henry Donahue

9

1 reference

15 March 2018

Charles D Smith

11

1 reference

15 March 2018

publication date

11 October 2010

1 reference

15 March 2018

published in

Inflammopharmacology

1 reference

15 March 2018

volume

19

1 reference

15 March 2018

issue

2

1 reference

15 March 2018

page(s)

75-87

1 reference

15 March 2018

https://scigraph.springernature.com/pub.10.1007/s10787-010-0060-6

exact match

0 references

cites work

Therapeutic options for rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1007%2FS10787-010-0060-6

Antitumor activity of sphingosine kinase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-010-0060-6

Pharmacology and antitumor activity of ABC294640, a selective inhibitor of sphingosine kinase-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-010-0060-6

The role of cytokines as inflammatory mediators in osteoarthritis: lessons from animal models

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-010-0060-6

Leukotriene B4 plays a critical role in the progression of collagen-induced arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-010-0060-6

Suppression of adjuvant arthritis of rats by a novel matrix metalloproteinase-inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-010-0060-6

Cytosolic Phospholipase A2α–deficient Mice Are Resistant to Collagen-induced Arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-010-0060-6

Utility of animal models for identification of potential therapeutics for rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-010-0060-6

The molecular pathogenesis of collagen-induced arthritis in mice--a model for rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-010-0060-6

Animal models of rheumatoid arthritis and their relevance to human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-010-0060-6

Ulcerogenic influence of selective cyclooxygenase-2 inhibitors in the rat stomach with adjuvant-induced arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-010-0060-6

Sphingosine kinase signalling in immune cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-010-0060-6

Mice deficient in sphingosine kinase 1 are rendered lymphopenic by FTY720.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-010-0060-6

Anti-inflammatory effects of sphingosine kinase modulation in inflammatory arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-010-0060-6

Distinct roles of sphingosine kinase 1 and 2 in murine collagen-induced arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-010-0060-6

Escherichia coli heat-labile enterotoxin B subunit prevents autoimmune arthritis through induction of regulatory CD4+ T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-010-0060-6

Sphingosine kinase: a point of convergence in the action of diverse neutrophil priming agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-010-0060-6

Pharmacologic manipulation of sphingosine kinase in retinal endothelial cells: implications for angiogenic ocular diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-010-0060-6

Suppression of ulcerative colitis in mice by orally available inhibitors of sphingosine kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-010-0060-6

Differential effect of FR122047, a selective cyclo-oxygenase-1 inhibitor, in rat chronic models of arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-010-0060-6

Sphingosine kinase: a mediator of vital cellular functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-010-0060-6

The sphingosine kinase 1/sphingosine-1-phosphate pathway mediates COX-2 induction and PGE2 production in response to TNF-alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-010-0060-6

A tumor necrosis factor receptor loop peptide mimic inhibits bone destruction to the same extent as anti-tumor necrosis factor monoclonal antibody in murine collagen-induced arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-010-0060-6

Sphingosine kinase: biochemical and cellular regulation and role in disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-010-0060-6

Recent insights in the pharmacological actions of methotrexate in the treatment of rheumatoid arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-010-0060-6

Tumor necrosis factor- induces adhesion molecule expression through the sphingosine kinase pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-010-0060-6

Sequential generation of cytokines during the initiative phase of inflammation, with reference to neutrophils

21 January 2018

1 reference

12 December 2020

Collagen-induced arthritis in mice: an animal model to study the pathogenesis of rheumatoid arthritis

1 reference

12 December 2020

Normal acute and chronic inflammatory responses in sphingosine kinase 1 knockout mice

1 reference

12 December 2020

Efficacy of a novel sphingosine kinase inhibitor in experimental Crohn's disease

1 reference

12 December 2020

The gastrin/cholecystokinin-B receptor antagonist L-365,260 reduces basal acid secretion and prevents gastrointestinal damage induced by aspirin, ethanol and cysteamine in the rat.

1 reference

12 December 2020

Rodent models of rheumatoid arthritis.

1 reference

12 December 2020

Discovery and evaluation of inhibitors of human sphingosine kinase

1 reference

12 December 2020

Prevention of splenic granuloma formation in adjuvant arthritis by 2-acetyl-4-tetrahydroxybutylimidazole (THI)

1 reference

12 December 2020

Differential effects of FK506 and methotrexate on inflammatory cytokine levels in rat adjuvant-induced arthritis

1 reference

12 December 2020

Combination therapy in rheumatoid arthritis: the animal model perspective

1 reference

12 December 2020

10.1007/S10787-010-0060-6

Identifiers

DOI

1 reference

15 March 2018

1 reference

15 March 2018